The Chloroquine Phosphate Tablets, cataloged under National Stock Number 6505-01-267-9662, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Chartwell Rx Llc. Government technical data includes 5 specifications, cited from the U.S. Government catalog. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-01-267-9662 |
| Primary Part Number | NDC62135-0717-26 |
| Item Name | Chloroquine Phosphate Tablets |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Chartwell Rx Llc |
| Status | ACTIVE |
| Therapeutic Equivalent | ARALEN BY SANOFI/WINTHROP PHARM. |
| Primary Container Content Quantity | 25.000 TABLETS |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | BOTTLE |
| Active Medicament Medicinal Strength | 500.000 MILLIGRAMS CHLOROQUINE PHOSPHATE ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| NDC62135-0717-26 PRIMARY | Chartwell Rx Llc (USA) |
| Reference | Meaning |
|---|---|
| NDC64980-0178-02 | 5/9 Secondary reference Rising Pharmaceuticals, Inc. |
| NDC00143-2125-22 | 5/9 Secondary reference Hikma Pharmaceuticals Usa Inc. |
NSN 6505-01-267-9662 is a Chloroquine Phosphate Tablets, manufactured by Chartwell Rx Llc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-267-9662 has 1 manufacturer part number on file: NDC62135-0717-26 (Chartwell Rx Llc).
Key specifications for NDC62135-0717-26: Therapeutic Equivalent: ARALEN BY SANOFI/WINTHROP PHARM.; Primary Container Content Quantity: 25.000 TABLETS; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: BOTTLE. 5 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.